JP2020515557A5 - - Google Patents

Download PDF

Info

Publication number
JP2020515557A5
JP2020515557A5 JP2019552891A JP2019552891A JP2020515557A5 JP 2020515557 A5 JP2020515557 A5 JP 2020515557A5 JP 2019552891 A JP2019552891 A JP 2019552891A JP 2019552891 A JP2019552891 A JP 2019552891A JP 2020515557 A5 JP2020515557 A5 JP 2020515557A5
Authority
JP
Japan
Prior art keywords
salt
compound selected
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019552891A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020515557A (ja
JP7032428B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2018/058056 external-priority patent/WO2018178227A1/en
Publication of JP2020515557A publication Critical patent/JP2020515557A/ja
Publication of JP2020515557A5 publication Critical patent/JP2020515557A5/ja
Application granted granted Critical
Publication of JP7032428B2 publication Critical patent/JP7032428B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019552891A 2017-03-31 2018-03-29 Mcl-1阻害剤の合成 Active JP7032428B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762479493P 2017-03-31 2017-03-31
US62/479,493 2017-03-31
PCT/EP2018/058056 WO2018178227A1 (en) 2017-03-31 2018-03-29 Synthesis of mcl-1 inhibitor

Publications (3)

Publication Number Publication Date
JP2020515557A JP2020515557A (ja) 2020-05-28
JP2020515557A5 true JP2020515557A5 (enExample) 2021-03-11
JP7032428B2 JP7032428B2 (ja) 2022-03-08

Family

ID=61827753

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019552891A Active JP7032428B2 (ja) 2017-03-31 2018-03-29 Mcl-1阻害剤の合成

Country Status (16)

Country Link
US (1) US11149024B2 (enExample)
EP (1) EP3601230B1 (enExample)
JP (1) JP7032428B2 (enExample)
KR (1) KR102604876B1 (enExample)
CN (1) CN110536884B (enExample)
AR (1) AR111304A1 (enExample)
AU (1) AU2018244180B2 (enExample)
CA (1) CA3056712A1 (enExample)
CO (1) CO2019010035A2 (enExample)
EA (1) EA038226B1 (enExample)
ES (1) ES2909751T3 (enExample)
IL (1) IL269410B2 (enExample)
MX (1) MX387814B (enExample)
TW (1) TWI781996B (enExample)
WO (1) WO2018178227A1 (enExample)
ZA (1) ZA201905645B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3781570A4 (en) 2018-11-22 2021-06-02 Ascentage Pharma (Suzhou) Co., Ltd. MACROCYCLIC INDOLES SERVING AS MCL-1 INHIBITORS
WO2020151738A1 (en) * 2019-01-23 2020-07-30 Ascentage Pharma (Suzhou) Co., Ltd. Macrocyclic fused pyrrazoles as mcl-1 inhibitors
ES2975083T3 (es) 2019-06-21 2024-07-03 Janssen Pharmaceutica Nv Inhibidores macrocíclicos de MCL-1
MX2022000390A (es) 2019-07-09 2022-02-10 Janssen Pharmaceutica Nv Derivados macrociclicos espirociclicos como inhibidores de mcl-1.
WO2021092053A1 (en) * 2019-11-08 2021-05-14 Unity Biotechnology, Inc. Mcl-1 inhibitor macrocycle compounds for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer
EP4061819A1 (en) 2019-11-21 2022-09-28 Janssen Pharmaceutica NV Macrocyclic indole derivatives as mcl-1 inhibitors
BR112022009754A2 (pt) 2019-11-21 2022-08-09 Janssen Pharmaceutica Nv Derivados macrocíclicos de sulfonila como inibidores de mcl-1
WO2021165370A1 (en) 2020-02-21 2021-08-26 Janssen Pharmaceutica Nv Macrocyclic indole derivatives as inhibitors of mcl-1
CA3178283A1 (en) 2020-05-29 2021-12-02 Frederik Jan Rita Rombouts Macrocyclic 7-pyrazol-5-yl-indole derivatives as inhibitors of mcl-1
US20230234969A1 (en) 2020-06-19 2023-07-27 Janssen Pharmaceutica Nv N-linked macrocyclic 7-(pyrazol-5-yl)-indole derivatives as inhibiors of mcl-1
CN115943146A (zh) 2020-06-19 2023-04-07 詹森药业有限公司 N-连接的大环4-(吡唑-5-基)-吲哚衍生物作为mcl-1抑制剂
CN115776888A (zh) 2020-07-08 2023-03-10 詹森药业有限公司 含大环醚的吲哚衍生物作为mcl-1抑制剂
WO2022032284A1 (en) * 2020-08-07 2022-02-10 Zeno Management, Inc. Macrocyclic compounds
CA3200758A1 (en) 2020-12-17 2022-06-23 Janssen Pharmaceutica Nv Branched macrocyclic 4-(pyrazol-5-yl)-indole derivatives as inhibitors of mcl-1
WO2022171782A1 (en) 2021-02-12 2022-08-18 Janssen Pharmaceutica Nv Macrocyclic 1,3-bridged 6-chloro-7-pyrazol-4-yl-1h-indole-2-carboxylate and 6-chloro-7-pyrimidin-5-yl-1h-indole-2-carboxylate derivatives as mcl-1 inhibitors for the treatment of cancer
EP4351564A1 (en) 2021-06-11 2024-04-17 Gilead Sciences, Inc. Combination mcl-1 inhibitors with anti-cancer agents
CA3222752A1 (en) 2021-06-11 2022-12-15 Gilead Sciences, Inc. Combination mcl-1 inhibitors with anti-body drug conjugates

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2915811A1 (en) * 2014-03-04 2015-09-09 Centre Régional de Lutte contre le Cancer - Centre François Baclesse MCL-1 modulating compounds for cancer treatment
US9949965B2 (en) * 2014-10-17 2018-04-24 Vanderbilt University Tricyclic indole Mcl-1 inhibitors and uses thereof
CN105061315B (zh) * 2015-08-06 2017-10-24 大连理工大学 一类1,5‑二苯基吡唑‑3‑羧酸类化合物及其应用
JP6894449B2 (ja) * 2016-04-22 2021-06-30 アストラゼネカ・アクチエボラーグAstrazeneca Aktiebolag 癌を治療するためのマクロ環状mcl1阻害剤
CN106478606B (zh) * 2016-09-21 2019-05-10 沈阳药科大学 N-取代吲哚类衍生物及其应用

Similar Documents

Publication Publication Date Title
JP2020515557A5 (enExample)
JP2019194236A5 (enExample)
JP2017008120A5 (enExample)
JP2018168171A5 (enExample)
JP2018024670A5 (enExample)
JP2019089762A5 (enExample)
JP2021020948A5 (enExample)
JP2018150298A5 (enExample)
JP2020007340A5 (enExample)
JP2020534795A5 (enExample)
JP2019068846A5 (enExample)
JP2019124943A5 (enExample)
JP2019030304A5 (enExample)
JP2017137500A5 (enExample)
JP2017514877A5 (enExample)
JP2018030858A5 (enExample)
JP2019031552A5 (enExample)
JP2021503553A5 (enExample)
JP2018521020A5 (enExample)
JP2019164961A5 (enExample)
JP2018116258A5 (enExample)
JP2021502339A5 (enExample)
JP2018162319A5 (enExample)
JP2018186811A5 (enExample)
JP2019505548A5 (enExample)